Trial
NCT04115059
Dasatinib In Waldenström Macroglobulinemia
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Jorge J. Castillo, MD
Collaborators
Bristol-Myers Squibb
Condition
Waldenstrom Macroglobulinemia
Intervention
Dasatinib
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-21